FGFR2 and neoplasm: Furthermore, to the best of our knowledge, the mutation in the FGFR2 juxtamembrane region of patient 2 has not yet been reported in any tumor, nor have FGFR downstream activation and response to FGFR inhibition been analyzed so far.